Monoxid De Azot Messer (Nitric Oxide)

Nitric oxide diffuses into the smooth muscle of pulmonary arteries and activates soluble guanylate cyclase. This enzyme increases cyclic GMP levels, leading to relaxation of the smooth muscle cells. The result is selective dilation of pulmonary vessels, reducing resistance and pressure without markedly affecting systemic circulation.

The dose of inhaled nitric oxide is individualized by the prescribing clinician based on the patient's age, weight, severity of disease, and response to therapy. Dosing is typically expressed in parts per million (ppm) of the inhaled gas and adjusted according to continuous monitoring of oxygenation and hemodynamics.

Safety data for inhaled nitric oxide in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician in consultation with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with systemic vasodilators, inhaled nitric oxide offers selective pulmonary vasodilation, minimizing systemic hypotension. Unlike other inhaled agents such as prostacyclin analogues, nitric oxide has a rapid onset and short half‑life, allowing precise titration. Choice of therapy depends on clinical context, patient tolerance, and institutional protocols.

The medical gas cylinders should be stored at ambient temperature, kept upright, and protected from heat, direct sunlight, and physical damage. Cylinders must be secured to prevent tipping, and any damaged or expired containers should be removed from service in accordance with local regulations.

The product is delivered via a calibrated inhalation system that mixes the nitric oxide gas with the patient’s breathing circuit. Administration is performed by trained healthcare professionals in a monitored setting, with continuous assessment of oxygen saturation, blood pressure, and methemoglobin levels.

Serious risks include severe hypotension, methemoglobinemia, and bronchospasm. Rarely, patients may develop pulmonary edema or allergic reactions. Continuous monitoring of hemodynamic parameters and methemoglobin levels is essential to detect and manage these complications promptly.

Patients with known hypersensitivity to nitric oxide, severe anemia, or those receiving contraindicated medications such as phosphodiesterase‑5 inhibitors should not be treated with this product. Additionally, use is not recommended in settings lacking appropriate respiratory monitoring and emergency support.